Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C

2006 ◽  
Vol 57 (2) ◽  
pp. 360-363 ◽  
Author(s):  
Francesco G. De Rosa ◽  
Olivia Bargiacchi ◽  
Sabrina Audagnotto ◽  
Silvia Garazzino ◽  
Giuseppe Cariti ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Acute Hepatitis ◽  
Sustained Virological Response ◽  
Interferon Alpha ◽  
Virological Response ◽  
Pegylated Interferon ◽  
Acute Hepatitis C ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B ◽  
Dose Dependent

scholarly journals Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin

Hepatology ◽  
2014 ◽  
Vol 59 (6) ◽  
pp. 2101-2109 ◽  
Author(s):  
Teresa Santantonio ◽  
Massimo Fasano ◽  
Evangelista Sagnelli ◽  
Paolo Tundo ◽  
Sergio Babudieri ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Acute Hepatitis ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Acute Hepatitis C ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

scholarly journals Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study

Hepatology ◽  
2006 ◽  
Vol 43 (2) ◽  
pp. 250-256 ◽  
Author(s):  
Johannes Wiegand ◽  
Peter Buggisch ◽  
Wulf Boecher ◽  
Stefan Zeuzem ◽  
Cornelia M. Gelbmann ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Acute Hepatitis ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Acute Hepatitis C ◽  
Hepatitis C Infection ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B ◽  
Acute Hcv

P.244 Pegylated interferon alpha-2a for treatment of acute hepatitis C in Egypt (ANRS 1213 trial)

2006 ◽  
Vol 36 ◽  
pp. S137
Author(s):  
S.A. Ismail ◽  
M.K. Mohamed ◽  
H. Mansour ◽  
C. Rekacewicz ◽  
R.R. Gad ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Acute Hepatitis ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Acute Hepatitis C ◽  
Pegylated Interferon Alpha
Sign in / Sign up

Export Citation Format

Share Document